aid: halia-therapeutics
name: Halia Therapeutics
description: 'Halia Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical
  company headquartered in Lehi, Utah, founded in 2017 and led by CEO Dr. David Bearss. Halia
  discovers and develops small-molecule therapies that target the immune system''s inflammatory
  response — chiefly allosteric NEK7/NLRP3 inflammasome inhibition and LRRK2 inhibition — to
  resolve the chronic inflammation that drives hematologic, metabolic and neurodegenerative
  disease. Its lead clinical program, ofirnoflast (HT-6184), holds FDA Fast Track and Orphan Drug
  designation for lower-risk myelodysplastic syndromes; HT-4253, an LRRK2 inhibitor aimed at
  neuroinflammation and Alzheimer''s prevention in APOE4 carriers, has completed a first-in-human
  Phase 1 study. The company also markets a "genetic resilience" research platform (GENMOR) built
  on family-cohort genomics. Halia is a drug developer, not a software vendor: it publishes a
  Webflow corporate site with pipeline, platform and press pages, and no developer program,
  public API, SDK or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/halia-therapeutics/refs/heads/main/apis.yml
image: https://cdn.prod.website-files.com/688b451b45ceaa63f2f18f66/688cae0819292502275bf280_Company%20Logo.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Clinical Trials
- Immunology
- Neuroscience
- Genomics
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://haliatx.com/
- type: About
  url: https://haliatx.com/about
- type: Blog
  url: https://haliatx.com/news
- type: Support
  url: https://haliatx.com/contact
- type: PrivacyPolicy
  url: https://haliatx.com/privacy-policy
- type: DomainSecurity
  url: security/halia-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Halia Therapeutics is a clinical-stage biopharmaceutical developer whose only public web
    property is a Webflow marketing site; every OpenAPI/GraphQL/MCP/A2A discovery path on
    haliatx.com returns a 404 HTML page, no api/dev/docs/portal subdomain resolves in DNS, and
    no GitHub organization exists under haliatx or halia-therapeutics.
  evidence:
  - url: https://haliatx.com/openapi.json
    status: 404
  - url: https://haliatx.com/.well-known/api-catalog
    status: 404
  - url: https://haliatx.com/.well-known/agent-card.json
    status: 404
  - url: https://api.github.com/orgs/haliatx
    status: 404
  - url: https://haliatx.com/
    status: 200
  checked: '2026-08-22'